Birdwatch Note Rating
2023-11-24 23:12:23 UTC - NOT_HELPFUL
Rated by Participant: FFAD1ABF136A25ADB4B63F5901F04A7F600C557256FFAF58E4FC0DB68DC2D62F
Participant Details
Original Note:
Claim is false. In the trial the effectiveness of the vaccine for severe RSV in babies was 81.8%. The clinical trial efficacy & safety data is publicly available. The available data are insufficient to establish a causal relationship between preterm birth & the vaccine https://www.fda.gov/news-events/press-announcements/fda-approves-first-vaccine-pregnant-individuals-prevent-rsv-infants https://www.nejm.org/doi/10.1056/NEJMoa2216480 https://www.fda.gov/media/169361/download
All Note Details